Close
0
Inquiry Basket
Hot Products

GlycoErase™ ALG9 Knockout Human Lung Cancer Cell A-427

CAT#: GLJF-0525-JF1286

Datasheet Request COA
Overview
Description
The ALG9 deficient A-427 cell line presents a valuable resource for evaluating defects in lipid-linked oligosaccharide assembly within the context of lung adenocarcinoma, as the absence of ALG9 disrupts N-glycosylation, thereby allowing researchers to investigate the correlation between N-glycosylation abnormalities and the initiation, advancement, and spread of lung adenocarcinoma, as well as to explore therapeutic avenues linked to ALG9 function.
Product Type
KO Cell Lines
Species
Human
Cell Morphology
Epithelial-like, adherent
Passage Ratio
1:2~1:3
Cell Line
A-427
Primary Disease
Non-Small Cell Lung Cancer
Lineage
Lung
Specification
Cell Viability
>90%
Sterility Test
The sterility test indicated an absence of microbial growth.
Identity Test
STR identification
Mycoplasma Test
Negative
Virus Test
Negative for HIV, HBV and HCV.
Genetic Stability Testing
We conduct cell genetic stability studies in full compliance with ICH guidelines. Our expertise enables us to design and execute a comprehensive testing program tailored to your specific needs and regulatory requirements.
Validation
PCR, Sanger Sequencing
Culture Medium
FBS & RPMI
Application
Functional assay
Size
1 M cells/vial*2
Product Format
Frozen
Shipping
Dry ice
Availability Status
Made to order
Handling Notes
Upon receipt, this product must be immediately transferred from dry ice to liquid nitrogen (-150°C to -190°C) and stored in a liquid nitrogen tank. Cell viability is critically dependent on proper handling. We cannot guarantee viability if these instructions are not strictly adhered to.
Product Disclaimer
This product is provided for research only, not suitable for human or animal use. Due to the inherent limitations of infectious agent testing, investigators must exercise extreme caution when handling cells provided by Creative Biolabs, treating all cells as potentially biohazardous.
Target Information
Target
ALG9
Full Name
ALG9 alpha-1,2-mannosyltransferase
Alternative Name
DIBD1
Location
11q23.1
Gene ID
Summary
Facilitates lipid-linked oligosaccharide assembly; mutations lead to CDG II (congenital disorder of glycosylation type II); multiple transcript variants (different isoforms) may influence enzyme specificity.
For Research Use Only.
Online Inquiry
Copyright © Creative Biolabs. All Rights Reserved.